Eos Advisory — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
Carcinotech produces 3D-bioprinted tumour models using established cancer cell lines and patient-derived tissue, offering assay-ready models and preclinical oncology services for drug testing and translational research.
BiotechDeep TechHealthtechScotland
Albert Nicholl(Director)Ishani Malhotra(Executive Officer, Director)Ian David Waddell(Director)
Wobble Genomics operates an RNA sequencing platform that captures full-length RNA transcripts to identify long RNA biomarkers and novel isoforms for precision medicine.
BiotechDeep TechDigital HealthHealthtechMedical DevicesEdinburgh
Joanna Smart(Director)Richard Izen Kuo(Executive Officer, Director)Lee James Lindley(Director)John Harris Leamon(Director)Trevor John Nicholls(Director)John Robert Fraser Duncan(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.